Sort
51,593 grants matching “hepatitis”
Genetic viral and host adaptations to breach species barriers of HCV
$402,500Alexander Ploss · Princeton University · R01 · FY2015 · AI
Fatty Acid Regulation of Liver Lipoprotein Production
$402,500Henry N Ginsberg · Columbia University Health Sciences · R01 · FY2010 · HL
Assembly and Secretion of ApoB Containing Lipoproteins
$402,500Henry N Ginsberg · Columbia University Health Sciences · R01 · FY2010 · HL
Fatty Acid Regulation of Liver Lipoprotein Production
$402,500Henry N Ginsberg · Columbia University Health Sciences · R01 · FY2011 · HL
Assembly and Secretion of ApoB Containing Lipoproteins
$402,500Henry N Ginsberg · Columbia University Health Sciences · R01 · FY2008 · HL
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · DK
Genetic viral and host adaptations to breach species barriers of HCV
$402,500Alexander Ploss · Princeton University · R01 · FY2016 · AI
Post-Translational and Epigenetic Control of Branched-Chain Amino Acid Metabolism
$402,500Matthew D Hirschey · Duke University · R01 · FY2021 · DK
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · DK
Trib1 regulation of hepatic lipid metabolism and atherogenesis
$402,500Daniel James Rader · University Of Pennsylvania · R01 · FY2018 · HL
Genetics of Hypertension
$402,500Ashok Kumar Kumar · New York Medical College · R01 · FY2011 · HL
Post-Translational and Epigenetic Control of Branched-Chain Amino Acid Metabolism
$402,500Matthew D Hirschey · Duke University · R01 · FY2020 · DK
Assembly and Secretion of ApoB Containing Lipoproteins
$402,500Henry N Ginsberg · Columbia University Health Sciences · R01 · FY2011 · HL
Trib1 regulation of hepatic lipid metabolism and atherogenesis
$402,500Daniel James Rader · University Of Pennsylvania · R01 · FY2019 · HL
Reversal of glutamine/glutamate metabolism and Retinopathy of Prematurity
$402,500Jonathan E Sears · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · EY
Regional Cholangiocyte Stress Responses in Biliary Disease
$402,500Michael A Pack · University Of Pennsylvania · R01 · FY2018 · DK
Reversal of glutamine/glutamate metabolism and Retinopathy of Prematurity
$402,500Jonathan E Sears · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · EY
Genetic viral and host adaptations to breach species barriers of HCV
$402,500Alexander Ploss · Princeton University · R01 · FY2017 · AI
Analysis of Host-Pathogen Interactions
$402,488Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Triplex HBV, HCV an HIV dipstick for blood banks
$402,468Diagnostics For The Real World, Ltd · R44 · FY2005 · HL
HCV Disease Management in HIV- HCV Coinfected IDUs
$402,468Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2008 · DA
Beta-catenin-driven hepatobiliary reprogramming as a therapeutic modality for cholangiopathies
$402,457Kari N Nejak-Bowen · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
BNIP3 and BNIP3L (NIX) in lipid homeostasis and growth control in the liver
$402,418Kay F Macleod · University Of Chicago · R01 · FY2023 · CA
BNIP3 and BNIP3L (NIX) in lipid homeostasis and growth control in the liver
$402,418Kay F Macleod · University Of Chicago · R01 · FY2025 · CA
NASH PROJECT
$402,407Arthur J McCullough · Case Western Reserve University · U01 · FY2007 · DK